|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(3S)-2-(2,2-diphenylacetyl)-6-methoxy-5-phenylmethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid |
Synonyms ![]() |
|
[S]-enantiomer of EMA400 [8] | [S]-enantiomer of PD-126,055 |
Database Links ![]() |
|
BindingDB Ligand | 50282401 |
ChEMBL Ligand | CHEMBL34124 |
GtoPdb PubChem SID | 252166586 |
PubChem CID | 9937291 |
Search Google for chemical match using the InChIKey | GHBCIXGRCZIPNQ-MHZLTWQESA-N |
Search Google for chemicals with the same backbone | GHBCIXGRCZIPNQ |
Search UniChem for chemical match using the InChIKey | GHBCIXGRCZIPNQ-MHZLTWQESA-N |
Search UniChem for chemicals with the same backbone | GHBCIXGRCZIPNQ |
Comments |
EMA401 is reported as a selective antagonist of the angiotensin type II receptor (AT2R) [5,8]. The compound is being assessed as a novel therapy for neuropathic pain [3]. Note that PubChem CID 23683656 refers to the potassium salt and that the sodium salt was used in [8]. |